RESUMEN
Metastasis is the main cause of poor prognosis of malignant tumors， and intervention with metastasis is the key measure in the treatment of malignant tumors. Hematogenous metastasis， the most common tumor metastasis， falls into the category of "Chuanshe" in traditional Chinese medicine （TCM）， with Qi deficiency and blood stasis as the critical pathogenesis. In the fight against malignant tumors， TCM emphasizes the reinforcement of healthy Qi and the elimination of pathogenic factors， exhibiting its action advantages of multiple targets， multiple mechanisms， and multiple levels. Extensive clinical evidence has shown the exact efficacy of Chinese herbal compounds designed for invigorating Qi and activating blood in delaying the progression of tumor disease and prolonging the survival period of patients. In view of the important role of hematogenous metastasis in the prognosis of tumors， more and more studies have explored the effects and mechanisms of Chinese herbal compounds capable of invigorating Qi and activating blood in intervening in hematogenous metastasis. This paper summarized the relevant literature reports in China and abroad on the intervention of Chinese herbal compounds capable of invigorating Qi and activating blood in the hematogenous metastasis of malignant tumors， in order to provide a theoretical basis for the clinical application of Qi-invigorating and blood-activating therapy in the treatment of malignant tumors. It has been found that Chinese herbal compounds formulated for invigorating qi and activating blood are effective in hindering several key steps in hematogenous metastasis through various mechanisms， including regulating the expression of cell adhesion molecules， inhibiting extracellular matrix degradation and angiogenesis， enhancing the killing effect of immunity， and improving blood hypercoagulability and hyperviscosity. Furthermore， the combination of invigorating Qi and activating blood targets the pathogenesis essence （Qi deficiency and blood stasis， characterized by sthenia in origin and asthenia in superficiality） of malignant tumor much better. Some comparative studies have demonstrated that the anti-metastasis effect of Qi-invigorating and blood-activating therapy is significantly stronger than that of the Qi-invigorating or blood-activating therapy alone， and such combination avoids the possible risk of the metastasis of malignant tumors triggered by the use of either of them. This study has provided some reference for the current clinical application of TCM for improving the prognosis of malignant tumors.
RESUMEN
Objective:To observe and evaluate the efficacy and safety of Ganduqing Granules in the treatment of common cold due to qi deficiency and pathogen invasion. Method:A multi-center， randomized， double-blind， and placebo-controlled clinical trial was conducted. One hundred and twenty patients were randomly divided into an experimental group （<italic>n</italic>=60） and a control group （<italic>n</italic>=60）. Patients in the experimental group were treated with oral Ganduqing Granules， 6 g per time， 3 times per day， while those in the control group received placebo， 6 g per time， 3 times per day. After treatment for 5 successive days in both groups， the overall remission rate， total score of primary symptoms， total score of secondary symptoms， total score of all symptoms， time required for overall symptom remission， and therapeutic efficacy against traditional Chinese medicine （TCM） syndrome in the two groups were analyzed in both full analysis set （FAS） and per-protocol set （PPS）， followed by the evaluation of safety in the safety set （SS）. Result:No drop-out was found in the experimental group， whereas 3 cases in the control group dropped out. After 5 days of treatment， the overall remission rate of the experimental group was significantly higher than that of the control group （<italic>P</italic><0.01）. The analysis in FAS and PDS revealed identical results. The experimental group was obviously better than the control group in improving the total scores of primary symptoms， secondary symptoms， and all symptoms （<italic>P</italic><0.01）. The analysis results in FAS and PDS were consistent. There was no significant difference in overall remission time between the two groups. The experimental group was remarkably superior to the control group in alleviating such symptoms as aversion to wind and cold， nasal congestion， runny nose， fatigue， shortness of breath， laziness to speak， dry throat， sore throat， cough， and expectoration （<italic>P</italic><0.05，<italic>P</italic><0.01）. The analysis results in FAS were the same as those in PDS. All the patients did not present with significant abnormalities in vital signs， blood routine test， or liver and kidney function tests after medication. There was no significant difference in the incidence of adverse events between the experimental group and the control group. Conclusion:Ganduqing Granules effectively alleviate the symptoms of patients with common cold and shorten the course of disease， without inducing obvious side effects.